Buccoadhesive buccal delivery systems for isosorbide dinitrate in the form of unidirectional buccal films were developed and characterized for improving bioavailability. The films were formulated by solvent casting method using different bioadhesive polymers like Carbopol 934P and polyvinyl pyrrolidone by using two different plasticizers propylene glycol and diethyl phthalate. Unidirectional release was achieved by preparing composite films with backing membrane. The films were characterized on the basis of their physical characteristics, bioadhesive performance, and other parameters. In vitro studies revealed that release rate of isosorbide dinitrate was higher from carbopol films containing ratio of Eudragit RL100 and polyvinyl pyrrolidine in proportion of 1:2 and 2:1, respectively by using both plasticizers. Drug diffusion from buccal films showed apparently zero order kinetics and release mechanism was diffusion controlled after considerable swelling. All the films exhibited sufficient in vitro bioadhesion strength. Promising formulations were further studied for temperature dependent stability studies. Results of our preliminary experiments indicate that, therapeutic level of isosorbide dinitrate can be achieved using this buccaladhesive formulation.
Substantial efforts have recently been focused upon isosorbide dinitrate. Mucoadhesive films of isosorbide placing a drug or drug delivery system in a particular dinitrate using solvent casting technique were prepared region of the body for extended period of time. This and evaluated for different parameters. need is not only for local targeting of drugs but also for a better control of systemic drug delivery 
MATERIALS AND METHODS
drug delivery systems are delivery systems, which utilize the property of bioadhesion of certain polymers, which Isosorbide dinitrate and Eudragit RL100 were obtained as become adhesive on hydration and hence can be used gift samples from Bangalore Pharmaceutical Research Lab, for targeting of drug to particular region of the body 2 .
Bangalore and Rohm America, Inc., Carbopol 934P and PVP were obtained as gift samples from Genuine Isosorbide dinitrate is a long acting nitrate used as an Chemical Co., Mumbai and S. D. Fine Chemicals, Mumbai, antianginal in myocardial infarction. The main drawback of respectively. conventional isosorbide dinitrate formulation is that it undergoes hepatic first pass metabolism by enzymatic denitration. Thus the plasma t ½ is 45-60 min thereby decreasing its bioavailability. The conventional sublingual tablets (5-10 mg) produce maximal concentration of the drug in plasma in 6 min and fall in concentration is rapid. Hence an alternative delivery system for improving the onset of action and t is needed.
½
The present work describes such delivery system, which will improve the onset of action and biological half-life of Preformulation study is one of the important prerequisite in development of any drug delivery system. Hence a preformulation study was carried out to check the compatibility between drug and various polymers. Infra red spectra of physical mixtures of polymer and drug were studied. Colorimetric method was used for the estimation of isosorbide dinitrate. The absorbance was measured at 550 nm www.ijpsonline.com dinitrate undergoes hepatic first pass metabolism and since the buccoadhesive formulation is meant to bypass the hepatic inactivation, 5 mg being the lowest strength was sought to be appropriate choice for the formulation.
Preparation of drug loaded buccoadhesive films 5-7 : Carbopol 934P, Eudragit RL100, and polyvinyl pyrrolidone polymers were used in preparation of films. Propylene glycol, diethyl phthalate were used as plasticizer and dimethyl sulfoxide as penetration enhancer. Buccal films were prepared by solvent casting technique. Small films of Thickness of films was determined using dial caliper. They were no much variation in the thickness of films and they were well within the range of 0.2-0.25 mm 13 . The mean film thickness was found to be 0.20 ± 0.0035, 0.214 ± 0.0044, 0.216 ± 0.0044, 0.224 ± 0.0044, 0.220 ± 0.0035 and 0.234 ± 0.0044, respectively for formulation F1, F2, F3, F4, F5 and F6.
The test for folding endurance ensures the tensile strength of the films. Folding endurance of the film was determined by repeatedly folding a small strip of film at 2 cm diameter, 0.2-0.3 mm thick and containing 5 mg drug the same place till it breaks 6, 12 . The number of times the were punched out from the cast films using a specially film could be folded at same place without breaking gave fabricated punch. The formula for various formulations the value of folding endurance. attempted has been given in Table 1 .
Test for content uniformity is an important parameter Polymethacrylate copolymer (Eudragit RL100) 2.5% w/v since it establishes uniform distribution of active ingredient was dissolved in acetone and propylene glycol as a in all the formulations 3 . Three patches were cut at random plasticizer was added to formulate backing membrane as locations from the drug-loaded film. Each film was described by solvent casting technique. Composite dissolved in 25 ml acetone:alcohol (1:1) and heated in patches were prepared by sticking the impermeable boiling water bath and diluted with distilled water to get backing membrane to one side of buccal patch with concentration in the range of 10 µg/ml. Colorimetric determination was made at 550 nm using suitable reagents.
Evaluation of buccoadhesive therapeutic system
In vitro bioadhesive studies 13,14 : of isosorbide dinitrate:
This study was undertaken to evaluate the performance of An acidic or alkaline formulation is bound to cause bioadhesive strength of the prepared formulations. irritation on the mucosal membrane and hence this Bioadhesive strength of buccal films was measured on parameter assumes significance while developing a the modified physical balance using the method described mucoadhesive formulation. The surface pH was by Gupta et al. The method used rat peritoneal determined by the method similar to that used by membrane as the model mucosal membrane. Bottenberg et al. A combined glass electrode was used for this purpose 9, 10 .
In vitro release studies by using dissolution apparatus (Paddle method) 7,13 : Swelling study was performed in order to evaluate the The drug release was determined using USP dissolution swelling capacity of the prepared formulations 7, 11 . The test apparatus Type II thermostated at 37±1° and stirred at percentage swelling was calculated using the formula, rate of 50 rpm. Sink condition was maintained throughout
percentage swelling (wet weight-dry weight)/wet weight. the study. Each film was fixed on a glass slide with the Films were weighed individually and data was analyzed help of cyanoacrylate adhesive so that the drug could be for mean weight and standard deviation 12 . released only from upper face. Slide was immersed in In vitro release studies by using Keshary-Chein diffusion cell: The diffusion study was carried out by using KesharyChein diffusion cell. The method used rat peritoneal (salivary pH 6.2) and the reservoir compartment 
�-�) F1, (�-�) F2, (�-�) F3, (�-�) F4, (�-�) F5 and (�-�)
thermostated at 37±1° at rate of 50 rpm. Aliquots were
F6
withdrawn at suitable intervals and assayed spectrophotometrically.
There is no much variation in the weight of the films, they were found to be 45. 
RESULTS AND DISCUSSION
folding endurance of the film was optimum and therefore the films exhibited good physical and
To ensure the compatibility of the drug with polymers mechanical properties.
preformulation studies were done using IR spectrum recorded on Impact-410 Nicolet, USA FT-IR by preparing of Carbopol 934P was reduced by addition and increasing ratio of Eudragit RL100 and increased by addition of PVP. The decrease in percentage swelling causes a decrease in drug release from the matrix.
indicating the compatibility between the drug and F1, F2, F3, F4, F5 , and F6, respectively and was found to be in the order of F1>F5≈F3>F2≈F6>F4. The drug content was lowered in F2-F6 due to varying in concentration of polymers and plasticizers used in the formulations.
In vitro bioadhesive study is very critical for successful utilization of these dosage forms. Hence, in vitro evaluation of buccal films was carried out using rat peritoneal membrane. This therefore gives the indirect measurement of bioadhesive strength in grams. The www.ijpsonline.com leads to controlled release of drug from mucoadhesive films.
From the in vitro dissolution profile the best promising formulations were selected and studied for diffusion studies. Promising formulations selected were F1, F2, F5, and F4. In vitro diffusion release data obtained by selected formulations are tabulated in Table 4 .
Optimized formulations were subjected to two different aggravated conditions of temperature 37±0.5° and 45±0.5°.
